Literature DB >> 22752306

Graded loss of tuberin in an allelic series of brain models of TSC correlates with survival, and biochemical, histological and behavioral features.

Elizabeth Yuan1, Peter T Tsai, Emily Greene-Colozzi, Mustafa Sahin, David J Kwiatkowski, Izabela A Malinowska.   

Abstract

Tuberous sclerosis complex (TSC) is a neurodevelopmental disorder with prominent brain manifestations due to mutations in either TSC1 or TSC2. Here, we describe novel mouse brain models of TSC generated using conditional hypomorphic and null alleles of Tsc2 combined with the neuron-specific synapsin I cre (SynIcre) allele. This allelic series of homozygous conditional hypomorphic alleles (Tsc2(c-del3/c-del3)SynICre(+)) and heterozygote null/conditional hypomorphic alleles (Tsc2(k/c-del3)SynICre(+)) achieves a graded reduction in expression of Tsc2 in neurons in vivo. The mice demonstrate a progressive neurologic phenotype including hunchback, hind limb clasp, reduced survival and brain and cortical neuron enlargement that correlates with a graded reduction in expression of Tsc2 in the two sets of mice. Both models also showed behavioral abnormalities in anxiety, social interaction and learning assays, which correlated with Tsc2 protein levels as well. The observations demonstrate that there are graded biochemical, cellular and clinical/behavioral effects that are proportional to the extent of reduction in Tsc2 expression in neurons. Further, they suggest that some patients with milder manifestations of TSC may be due to persistent low-level expression of functional protein from their mutant allele. In addition, they point to the potential clinical benefit of strategies to raise TSC2 protein expression from the wild-type allele by even modest amounts.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22752306      PMCID: PMC3441124          DOI: 10.1093/hmg/dds262

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  52 in total

1.  A novel missense mutation in the GTPase activating protein homology region of TSC2 in two large families with tuberous sclerosis complex.

Authors:  L Khare; G D Strizheva; J N Bailey; K S Au; H Northrup; M Smith; S L Smalley; E P Henske
Journal:  J Med Genet       Date:  2001-05       Impact factor: 6.318

2.  Short and long-term motor skill learning in an accelerated rotarod training paradigm.

Authors:  Manuel M Buitrago; Jörg B Schulz; Johannes Dichgans; Andreas R Luft
Journal:  Neurobiol Learn Mem       Date:  2004-05       Impact factor: 2.877

3.  Genetic aspects of tuberous sclerosis in the west of Scotland.

Authors:  J R Sampson; S J Scahill; J B Stephenson; L Mann; J M Connor
Journal:  J Med Genet       Date:  1989-01       Impact factor: 6.318

4.  Genotype and cognitive phenotype of patients with tuberous sclerosis complex.

Authors:  Agnies M van Eeghen; Margaux E Black; Margaret B Pulsifer; David J Kwiatkowski; Elizabeth A Thiele
Journal:  Eur J Hum Genet       Date:  2011-12-21       Impact factor: 4.246

5.  Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain.

Authors:  Y Zhu; M I Romero; P Ghosh; Z Ye; P Charnay; E J Rushing; J D Marth; L F Parada
Journal:  Genes Dev       Date:  2001-04-01       Impact factor: 11.361

6.  Social amnesia in mice lacking the oxytocin gene.

Authors:  J N Ferguson; L J Young; E F Hearn; M M Matzuk; T R Insel; J T Winslow
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

7.  Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures.

Authors:  Erik J Uhlmann; Michael Wong; Rebecca L Baldwin; M Livia Bajenaru; Hiroaki Onda; David J Kwiatkowski; Kelvin Yamada; David H Gutmann
Journal:  Ann Neurol       Date:  2002-09       Impact factor: 10.422

8.  A family with seizures and minor features of tuberous sclerosis and a novel TSC2 mutation.

Authors:  S E O'Connor; D J Kwiatkowski; P S Roberts; R L Wollmann; P R Huttenlocher
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

Review 9.  Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice.

Authors:  A Holmes; C C Wrenn; A P Harris; K E Thayer; J N Crawley
Journal:  Genes Brain Behav       Date:  2002-01       Impact factor: 3.449

10.  Selective nicotinic receptor consequences in APP(SWE) transgenic mice.

Authors:  Ivan Bednar; David Paterson; Amelia Marutle; Therese M Pham; Marie Svedberg; Ewa Hellström-Lindahl; Malahat Mousavi; Jennifer Court; Christopher Morris; Elaine Perry; Abdul Mohammed; Xiao Zhang; Agneta Nordberg
Journal:  Mol Cell Neurosci       Date:  2002-06       Impact factor: 4.314

View more
  27 in total

1.  mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle.

Authors:  Issam Ben-Sahra; Gerta Hoxhaj; Stéphane J H Ricoult; John M Asara; Brendan D Manning
Journal:  Science       Date:  2016-02-12       Impact factor: 47.728

2.  Chronic mTORC1 inhibition rescues behavioral and biochemical deficits resulting from neuronal Depdc5 loss in mice.

Authors:  Christopher J Yuskaitis; Leigh-Ana Rossitto; Sarika Gurnani; Elizabeth Bainbridge; Annapurna Poduri; Mustafa Sahin
Journal:  Hum Mol Genet       Date:  2019-09-01       Impact factor: 6.150

3.  Delving Deeper into DEPDC5.

Authors:  Laura A Jansen
Journal:  Epilepsy Curr       Date:  2018 May-Jun       Impact factor: 7.500

4.  Inactivation of Tsc2 in Abcg2 lineage-derived cells drives the appearance of polycystic lesions and fibrosis in the adult kidney.

Authors:  Leslie S Gewin; Megan E Summers; Julie W Harral; Christa F Gaskill; Stellor Nlandu Khodo; Surekha Neelisetty; Timothy M Sullivan; Katharina Hopp; J Jeffrey Reese; Dwight J Klemm; Valentina Kon; Kevin C Ess; Wei Shi; Susan M Majka
Journal:  Am J Physiol Renal Physiol       Date:  2019-08-28

5.  Coordinated regulation of protein synthesis and degradation by mTORC1.

Authors:  Yinan Zhang; Justin Nicholatos; John R Dreier; Stéphane J H Ricoult; Scott B Widenmaier; Gökhan S Hotamisligil; David J Kwiatkowski; Brendan D Manning
Journal:  Nature       Date:  2014-07-13       Impact factor: 49.962

6.  A mouse model of DEPDC5-related epilepsy: Neuronal loss of Depdc5 causes dysplastic and ectopic neurons, increased mTOR signaling, and seizure susceptibility.

Authors:  Christopher J Yuskaitis; Brandon M Jones; Rachel L Wolfson; Chloe E Super; Sameer C Dhamne; Alexander Rotenberg; David M Sabatini; Mustafa Sahin; Annapurna Poduri
Journal:  Neurobiol Dis       Date:  2017-12-20       Impact factor: 5.996

7.  mGluR5 Modulation of Behavioral and Epileptic Phenotypes in a Mouse Model of Tuberous Sclerosis Complex.

Authors:  Elyza Kelly; Samantha M Schaeffer; Sameer C Dhamne; Jonathan O Lipton; Lothar Lindemann; Michael Honer; Georg Jaeschke; Chloe E Super; Stephen Ht Lammers; Meera E Modi; Jill L Silverman; John R Dreier; David J Kwiatkowski; Alexander Rotenberg; Mustafa Sahin
Journal:  Neuropsychopharmacology       Date:  2017-12-05       Impact factor: 7.853

8.  Altered cerebellar connectivity in autism and cerebellar-mediated rescue of autism-related behaviors in mice.

Authors:  Catherine J Stoodley; Anila M D'Mello; Jacob Ellegood; Vikram Jakkamsetti; Pei Liu; Mary Beth Nebel; Jennifer M Gibson; Elyza Kelly; Fantao Meng; Christopher A Cano; Juan M Pascual; Stewart H Mostofsky; Jason P Lerch; Peter T Tsai
Journal:  Nat Neurosci       Date:  2017-10-30       Impact factor: 24.884

9.  Prenatal rapamycin results in early and late behavioral abnormalities in wildtype C57BL/6 mice.

Authors:  Peter T Tsai; Emily Greene-Colozzi; June Goto; Stefanie Anderl; David J Kwiatkowski; Mustafa Sahin
Journal:  Behav Genet       Date:  2012-12-12       Impact factor: 2.805

Review 10.  A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.

Authors:  David M Feliciano; Tiffany V Lin; Nathaniel W Hartman; Christopher M Bartley; Cathryn Kubera; Lawrence Hsieh; Carlos Lafourcade; Rachel A O'Keefe; Angelique Bordey
Journal:  Int J Dev Neurosci       Date:  2013-02-26       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.